Actively Recruiting
Communication Issues in Patient and Provider Discussions of Immunotherapy
Led by Emory University · Updated on 2026-04-06
125
Participants Needed
2
Research Sites
579 weeks
Total Duration
On this page
Sponsors
E
Emory University
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This trials studies communication issues in patient and provider discussions about immunotherapy. The goal of this study is to describe where patients have heard about immunotherapy, what the participants understand about it, how physicians and other healthcare workers describe immunotherapy, and how educational videos may support patient knowledge about immunotherapy.
CONDITIONS
Official Title
Communication Issues in Patient and Provider Discussions of Immunotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients and providers who may have a discussion about immunotherapy at the Winship Cancer Institute
- Any cancer patient for educational video testing
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, United States, 30322
Actively Recruiting
2
Atlanta VA Medical Center
Decatur, Georgia, United States, 30033
Actively Recruiting
Research Team
R
Rebecca Pentz, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here